Raymond Gilmartin

[1] Gilmartin then moved to Merck & Co, Inc., hired as president and CEO in 1994, and adding the role of chairman the same year upon retirement of P. Roy Vagelos.

[1][2] The style of management that I have, basically, is to recognize the fact that I'll never be as expert in any of the areas of the company as some of my direct reports are.

[1] During his tenure, Gilmartin oversaw Merck's response to two patent cliffs and consistently rejected the prospect of merging the company with a rival and maintained an emphasis on original research as opposed to joining a growing trend of in-licensing late-state drug prospects.

[1] Gilmartin's management style was characterized by delegation of day-to-day activities while maintaining a focus on strategic planning and decision making.

[5] Gilmartin has also served as a member of the board of advisors to the dean of Harvard Business School.